News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Obefazimod hits targets in identical trials on active UC
31 Dec 2025
byAudrey Abella
Two phase III induction trials have demonstrated the efficacy and safety of obefazimod, an oral, first-in-class, small molecule, for the treatment of adults with moderate-to-severe ulcerative colitis (UC).








